Senotoxins target senescence via lipid binding specificity, ion imbalance and lipidome remodeling

Javier Moral-Sanz1,2, Isabel Fernández-Carrasco3, Valentina Ramponi4

  • 1Translational Venomics Group, Madrid Institute for Advanced Studies in Nutrition (IMDEA Nutrition), Madrid, Spain. javier.moralsanz@syneoshealth.com.

Nature Aging
|January 12, 2026
PubMed

Insights

Sticholysin I (StnI) and its variant StnIG are novel senotoxins that selectively kill senescent cancer cells. This discovery offers a new strategy to enhance chemotherapy effectiveness and treat solid tumors.

Area of Science:

  • Cellular senescence
  • Cancer biology
  • Pharmacology

Background:

  • Cellular senescence drives aging and hinders tumor progression but can promote inflammation and relapse.
  • Persistent senescent cells in the tumor microenvironment can compromise chemotherapy efficacy.

Purpose of the Study:

  • To identify and characterize senolytic agents targeting chemotherapy-induced senescent cells.
  • To explore the therapeutic potential of sticholysin I (StnI) and its engineered variant (StnIG) in cancer therapy.

Main Methods:

  • Investigated the senolytic properties of StnI and StnIG on senescent cancer and primary cells.
  • Analyzed the mechanism of action, including membrane binding and ion flux.
  • Evaluated the in vivo efficacy of StnIG in combination with chemotherapy in mouse models of solid tumors.

Main Results:

  • StnI and StnIG selectively reduced the viability of senescent cells.
  • Selectivity is mediated by binding to specific lipids and compromised membrane asymmetry in senescent cells.
  • StnIG induced ion influxes (Na+, Ca2+) and efflux (K+), leading to apoptosis and pyroptosis.
  • StnIG synergized with chemotherapy to achieve tumor remission in mice.

Conclusions:

  • StnI and StnIG function as senotoxins, selectively eliminating senescent cells.
  • These senotoxins have potential as a novel therapeutic strategy to enhance cancer chemotherapy.
  • StnIG demonstrates translational potential for improving solid tumor treatment outcomes.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.3K
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.1K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.2K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.8K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K